Clinical Trials Related to Non-small Cell Lung Cancer

Related studies linked through entity extraction aliases.

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Status: NOT_YET_RECRUITING
Phase: PHASE3

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

Status: NOT_YET_RECRUITING
Phase: PHASE1

Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)

Status: RECRUITING
Phase: NA

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

Status: RECRUITING
Phase: NA

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE2

SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ

Status: NOT_YET_RECRUITING
Phase: PHASE3

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

3D Virtual Resection for Predicting Lung Function in VATS

Status: RECRUITING
Phase: N/A

Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC

Status: COMPLETED
Phase: NA

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

Status: RECRUITING
Phase: PHASE3

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Status: RECRUITING
Phase: PHASE2

A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC

Status: NOT_YET_RECRUITING
Phase: NA

Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE3

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Status: RECRUITING
Phase: PHASE3

CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

Status: RECRUITING
Phase: N/A

A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression

Status: NOT_YET_RECRUITING
Phase: PHASE2

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

Status: NOT_YET_RECRUITING
Phase: NA

Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer

Status: NOT_YET_RECRUITING
Phase: NA

Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC

Status: NOT_YET_RECRUITING
Phase: N/A